Trial Profile
Melatonin agonist for prevention of postoperative delirium.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Nov 2011
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 19 Nov 2011 New trial record